Nemera will be exhibiting and presenting a poster at ARVO 2017!

NEMERA NEWS

Nemera will join the leaders in eye and vision research from around the world at next ARVO, which will take place in Baltimore, from May 7th to 11th

Recognized as one of the top 50 medical meetings by the Healthcare Convention & Exhibitors Association, the Association for Research in Vision and Ophthalmology (ARVO) is the world’s leading educational and networking forum for clinicians, researchers, students and trainees in the fields of vision research and eye science.

Nemera will participate and speak to present its innovative preservative-free multidose eyedropper Novelia®.

Our poster, entitled “How to deliver preservative-free eye drops in a multidose system with a safer alternative to filters?”, will be presented on May 11th.

Nemera will also launch a new variant for its system: the Novelia® Vented Cap!

Vented Cap 06                    Vented Cap 04

The Novelia® Vented Cap has been specifically designed to address the challenges of particularly sticky formulations.

This new variant removes and dries residual liquid on the dropper tip, allowing continuously calibrated drops throughout usage with these specific formulations.

Spotlight ARVO2017_posting

Don’t miss out this event and contact us from now on to schedule a meeting with the Nemera team!


Attached documents:


About Nemera

Nemera is a world leader in the design, development and manufacturing of drug delivery devices for the pharmaceutical, biotechnology & generics industries.

Nemera’s services and products cover several key delivery routes: Inhalation (pMDIs, DPIs), Ophthalmic (multi-dose, preservative-free eyedroppers), Nasal, buccal, auricular (pumps, valves and actuators for sprays), Dermal and transdermal (airless & atmospheric dispensers), Parenteral (auto-injectors, pens, safety devices & implanters).

Nemera always puts patients first, providing the most comprehensive range of devices in the industry, including off-the-shelf innovative systems, customized design development and contract manufacturing.